Breakthrough in ovarian cancer detection ABC Online - ‎2 hours ago‎ TONY EASTLEY: Medical researchers say they've made a breakthrough which could lead to the earlier detection of ovarian cancer. A team from the Garvan Institute has found six genes which are common in women with the disease. Biochemical changes in the ...

Bakers Square & guests raise cash for ovarian cancer Winnetka Talk - ‎3 hours ago‎ $13163 was raised to support the Foundation for Women's Cancer during the month of September in honor of Ovarian Cancer Awareness Month. The check presentation ceremony was held at the Bakers Square restaurant location in Wilmette, 200 Skokie Blvd. on ...

Hobsons Bay Leader

A personal journey Hobsons Bay Leader - ‎7 hours ago‎ BEFORE she was diagnosed with ovarian cancer, Paula Benson would never have described herself as a runner - now she's tackling triathlons.

Family Plans Run for Ovarian Cancer Awareness NBC 6 Miami - ‎6 hours ago‎ By Willard Shepard A family who is facing the final days of their loved one's battle with ovarian cancer is honoring her by continuing to try to educate people about the illness.

Poulsbo teen's jewelry sales help in ovarian cancer fight Kitsap Sun - ‎Jan 22, 2012‎ Last year, she donated more than $10000 to the University of Washington Medical Center, specifically to help Dr. Elizabeth Swisher in her research to find a cure for ovarian cancer. MEEGAN M. REID/KITSAP SUN Necklaces await finishing at the home of ...

gulfnews.com

Qatar researchers find potential new ovarian cancertreatment gulfnews.com - ‎Jan 22, 2012‎ Manama: A medical college in Qatar said that its researchers have made a possible breakthrough in the way ovarian canceris treated.

EntreMed lands $10M deal to fund cancer drug trials FierceBiotech - ‎9 hours ago‎ With the funding, the company has high hopes to advance its lead drug, ENMD-2076, an Aurora A/angiogenic kinase inhibitor in midstage trials to treat ovarian cancer. The drug is also being investigated in initial trials for patients with solid tumors, ...

Myriad Genetics acquires patent on another breast cancer-linked gene BioNews - ‎11 hours ago‎ Mutations of the gene have been associated with an increased risk for hereditary breast and ovarian cancer and the company now hopes to develop a commercial test for RAD51C.

Chemo drug drives growth of some tumors Science News - ‎4 hours ago‎ By Tina Hesman Saey Chemotherapy drugs designed to kill tumors may actually encourage ovarian cancer by stimulating the growth of cells that give rise to the malignancy, a new study finds.

Global drug shortages to hit Australia ABC Online - ‎18 hours ago‎ Ovarian Cancer Australia chief executive Annabelle Davis says her group has told hundreds of its members, who rely on a drug called Doxil, to start preparing.

Ovarian cancer funding battle ABC Online - ‎Jan 20, 2012‎ BRENDAN TREMBATH: An eminent cancer specialist and Australia's peak research council are at odds over funding for a lethal disease.

MyFox Dallas

Hometown Hero: Ovarian Cycle Dallas MyFox Dallas - ‎4 hours ago‎ DALLAS - Ovarian cancer is an insidious disease. Far too often; by the time a woman is diagnosed; she is in the advanced stages of this disease, which will kill 15000 women every year.

The Associated Press

Too many tests? Routine checks getting second look The Associated Press - ‎5 hours ago‎ Pelvic exams aren'ta good screening tool for ovarian cancer, and shouldn't be required to get birth control pills, the report says.

Symptom Screening Indexes Do Not Detect Early Ovarian Cancer Medscape - ‎Jan 20, 2012‎ July 20, 2012 - In an attempt to diagnose ovarian cancer at an earlier and more curative stage, the use of symptom indexes is increasing.

Patients, clinicians welcome Avastin for ovarian cancer Pharma Times - ‎Jan 19, 2012‎ Roche's Avastin (bevacizumab) has received approval from the European Medicines Agency (EMA) for the treatment of advanced ovarian cancer, in combination with standard chemotherapy. The drug is now available to patients in England through application ...

Immunocellular Therapeutics (IMUC): Targeting Cancer Stem Cells BiotechStockTrader.com - ‎12 hours ago‎ The capital raise ensures enough money to last until the end of the Phase II study and funds additional studies in ovarian cancer and recurrent GBM. With a market capitalization of just $42 million, IMUC appears to be significantly undervalued compared ...

The Virtual Medical Centre

Faulty proteins help identify new treatments for ovarian cancer The Virtual Medical Centre - ‎Jan 19, 2012‎ A constellation of defective proteins suspected in causing a malfunction in the body's ability to repair its own DNA could be the link scientists need to prove a new class of drugs will be effective in treating a broad range of ovarian cancerpatients, ...

VentiRx Pharmaceuticals Publishes Preclinical Data of Novel TLR8 Agonist, VTX ... MarketWatch (press release) - ‎14 hours ago‎ Clinical trials of VTX-2337 currently underway include a combination study with chemotherapy in late stage ovarian cancer and a combination trial with cetuximab in head and neck cancer patients. In addition, a trial of VTX-2337 in combination with ...

Yahoo! News UK

Ovarian Cancer Drug 'Heralds New Era Of Hope' Yahoo! News UK - ‎Jan 16, 2012‎ By Thomas Moore, health correspondent | Sky News - 12 hours ago A drug that significantly extends the lives of women with ovarian cancer has been approved by the European medicines' watchdog. Studies show patients taking the drug Avastin live an extra ...

Targeted Cryoablation Boosts Survival in Ovarian Cancer Medscape - ‎Jan 19, 2012‎ January 19, 2012 - Multisite cryoablation of metastatic epithelial ovarian cancer is well tolerated, has a 5-year overall survival rate of 30%, and is cost effective, compared with other forms of adjuvant therapy, investigators reported at the ...